Xconomy reviews VC activity in Metro Detroit

The new news site in town takes on Metro Detroit's emerging venture capital scene and the streak of investments it has been on lately.


There are three reasons Michigan can feel good about a recent $8 million venture capital investment in Detroit-based medical imaging company Delphinus Medical Technologies.

  • It is an investment in a Michigan company;
  • The investment comes from an all-Michigan VC team;
  • It is an investment in Michigan-grown technology developed in one of the state's premier research institutions -- one that deals with real-life cancer cases every day.

Delphinus Medical's breast-cancer-detection technology, SoftVue, has been undergoing development at the Barbara Ann Karmanos Cancer Institute in Detroit for the past 10 years. Unlike mammography, it does not use radiation or compression to image the breast to detect early stages of breast cancer.

Read the rest of the story here and more here and here.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.